FEB 04, 2021 2:33 PM PST

Microchip models tumor‐immune interactions to predict immunotherapy effectiveness

A team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a microchip system that models immune checkpoint inhibitors in order to improve understanding of tumor interactions. The system is capable of predicting which patients will respond best to certain immunotherapies. The TIBI team’s results are published in the journal Nano-Micro Small.

Because patient response to immunotherapy is so varied, medical professionals have been long searching for a way to process large amounts of immunotherapy drugs against in vivo tumor cells quickly. This research aims to address that gap in capability, focusing specifically on T-cell checkpoint inhibitor therapies.

"Bringing ways to optimize clinical decisions and personalized medicine for patients is a top goal at our institute," comments Ali Khademhosseini, Ph.D., director and CEO of the Terasaki Institute. "This work is a significant step towards achieving that goal in the realm of cancer immunotherapy."

The microchip models tumor‐immune interactions by monitoring T cell inhibition and reactivation in what the researchers call an immunotherapeutic high‐throughput observation chamber (iHOC). Measuring tumor infiltration and interleukin‐2 (IL‐2) secretion, the iHOC evaluates the effect of anti‐PD‐1 antibodies on cancer spheroids and T cells.

"The features of our microwell-based chip is the key to our successful development of an immunoactive tissue model," said researcher Wujin Sun, Ph.D. "The chip's transparency allows for direct microscopic observation. And its design allows for high-volume testing, which lends itself well to the rapid screening of immunotherapeutic drugs."

Various follow-up tests showed that the microchip was in fact able to assess high-volumes of checkpoint inhibitor drugs against tumor cells. The team says they are hopeful that the chip can be used not only for the breast cancer tumor cells they used in their experiments but for other types of cancer cells as well.

Sources: Nano-Micro Small, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 10, 2021
Cancer
Advancements in nanotech pave the way for improved chemotherapy
MAY 10, 2021
Advancements in nanotech pave the way for improved chemotherapy
New research from Massachusetts General Hospital (MGH) reports on a development in improving the effectiveness of c ...
MAY 20, 2021
Cancer
High red meat consumption and low education level associated with early-onset colorectal cancer
MAY 20, 2021
High red meat consumption and low education level associated with early-onset colorectal cancer
Research published recently in JNCI Cancer Spectrum reports that higher red meat and alcohol consumption, as well as low ...
JUN 04, 2021
Cancer
Cancer patients with COVID-19 fare better with remote health monitoring
JUN 04, 2021
Cancer patients with COVID-19 fare better with remote health monitoring
A new study presented last week at the American Society of Clinical Oncology Annual Meeting after its publication in the ...
JUN 16, 2021
Cancer
New drug attacks pancreatic tumors with mutant KRAS addiction
JUN 16, 2021
New drug attacks pancreatic tumors with mutant KRAS addiction
Pancreatic cancer is notoriously difficult to detect in early stages, which is why it is associated with a low survival ...
JUN 21, 2021
Cancer
Analyzing breast implant topography and associated immune responses
JUN 21, 2021
Analyzing breast implant topography and associated immune responses
In an effort to understand how breast implants influence the immune system, researchers from MIT have led an analysis to ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
Loading Comments...